Showing 2581-2590 of 7669 results for "".
- Aditxt, Inc. Successfully Completes Preclinical Toxicity Study of Its Psoriasis Drug Candidate ADI-100https://practicaldermatology.com/news/aditxt-inc-successfully-completes-preclinical-toxicity-study-of-its-psoriasis-drug-candidate-adi-100/2461260/Aditxt, Inc.’s therapeutic program Adimune has successfully completed a toxicology study that indicates the safety profile of ADI-100, the Company’s immunotherapeutic technology drug that addresses rejection of transplanted organs, skin allografting, autoimmune diseases and allergies. The toxico…
- Cynosure's New Tempsure eyeEnvi Handpiece Offers Improved Function and Greater Comforthttps://practicaldermatology.com/news/cynosures-new-tempsure-eyeenvi-handpiece-offers-improved-function-and-greater-comfort/2461258/Cynosure has added a new Tempsure eyeEnvi handpiece to its portfolio. Featuring innovative ergonomic pencil grip design and lighter piston tension required to activate the treatment, the company says the new handpiece is more comfortable for patients and providers, heating thinner tissue more effec…
- Study: Colorescience’s All Calm Regimen Reduces Redness, Inflammationhttps://practicaldermatology.com/news/study-coloresciences-all-calm-regimen-reduces-redness-inflammation/2461253/Colorescience’s All Calm Regimen calms inflammation and reduces redness, according to a new study in the Journal of Cosmetic Dermatology. The 12-week study consisted of two subject groups. Group A subjects had not used any professional grade topical skincare, office-based treatments, or prescripti…
- FDA Clears Soligenix's Synthetic Hypericin for Phase 2 Clinical Trial in Psoriasishttps://practicaldermatology.com/news/fda-clears-soligenixs-synthetic-hypericin-for-phase-2-clinical-trial-in-psoriasis/2461250/The U.S. Food and Drug Administration (FDA) has cleared Soligenix’s Investigational New Drug (IND) application for a Phase 2a clinical trial of topically-applied SGX302 (synthetic hypericin). Patient enrollment is slated to begin in the fourth quarter of 2022. "During the last year, we have made …
- NYC PrideFest: Galderma Aesthetics to Participatehttps://practicaldermatology.com/news/nyc-pridefest-galderma-aesthetics-to-participate/2461249/Galderma is participating in New York City's official LGBTQIA+ Pride (NYC Pride) event. This month marks the official launch of Restylane's "XpresYourself" communications campaign, which gives a nod to Restylane's XpresHAn Technology™, a unique manufacturing process in four Restylane products that …
- Cool News on Ice-slurry Injections for Subcutaneous Body Fat Reductionhttps://practicaldermatology.com/news/cool-news-on-ice-slurry-injections-is-for-subcutaneous-body-fat-reduction/2461247/Cryolipolysis with injectable ice-slurry may soon become an efficient, effective and customizable method of body sculpting, according to new research ine Lasers in Surgery and Medicine. Our sister magazine Modern Aesthetics®, forecasted that this ice slurry fat melting technology will be the next …
- Sciton Taps Bryant Wong as First Chief Financial Officerhttps://practicaldermatology.com/news/sciton-taps-bryant-wong-as-first-chief-financial-officer/2461246/Bryant Wong is Sciton’s first Chief Financial Officer, effective immediately. The announcement was made at Sciton's 25th Anniversary celebration. The year 2022 exemplifies Sciton's ongoing commitment to quality and improvement, with recognition such as 2022 Company of the Year by MedTech Magazine,…
- The Aeshetic Show: Organizers Highlight Top Reasons to Attendhttps://practicaldermatology.com/news/the-aeshetic-show-organizers-highlight-top-reasons-to-attend/2461244/Unique in its multidisciplinary approach, The Aesthetic Show has, for more that 15 years, covered the rapidly-expanding field of aesthetic medicine. Attendees can unite with contemporaries across various medical disciplines, learn trailblazing techniques, and discover the groundbreaking solutions r…
- With New Roles for Company Vets, Crown Doubles Down on Commitment to Aestheticshttps://practicaldermatology.com/news/with-new-roles-for-industry-vets-crown-doubles-down-on-commitment-to-aesthetics/2461242/Joe Proctor and Michael McKenna are stepping into new roles at Crown Laboratories. Joe Proctor will transition from General Manager, Aesthetics into the Head of Innovation and Corporate Development for Crown Aesthetics. Mr. Proctor is the founder of Crown Aesthetics and SkinPen. He launched Bellu…
- Dermatologists Rule for Cosmetic Procedures and Skin Care Decisionshttps://practicaldermatology.com/news/dermatologists-rule-for-cosmetic-procedures-and-skin-care-decisions/2461241/Dermatologists rank as the number one influencer among 16 factors that impact consumers’ decisions to have a cosmetic procedure, according to the 2021 American Society for Dermatologic Surgery (ASDS) Consumer Survey on Cosmetic Dermatologic Procedures. When selecting a practitioner, the specialty …